Margaret van Heek - Concepedia

Author

Margaret van Heek

Merck & Co., Inc., Rahway, NJ, USA (United States)

Also Known As

M Van Heek, M. VAN HEEK, M. Van Heek, M. van Heek, Margaret Van Heek, Margaret van Heek

Publications

3.9K

Citations

H-Index

Concepts

All Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)AGCO (United Kingdom)Cornell University

About

Margaret van Heek is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, pharmacology, and physiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	20	31	2.5K
2	Biochemistry	16	23	1.3K
3	Health Sciences	12	12	1.8K
4	Natural Sciences	9	9	210
5	Cellular Physiology	1	1	329

Margaret van Heek

Publications

3.8K

Citations

H-Index

Page 1

	Year	Citations
Diet-induced obese mice develop peripheral, but not central, resistance to leptin. Margaret van Heek, Douglas S. Compton, C F France, Journal of Clinical Investigation NutritionImmunologyGastrointestinal Peptide HormoneObesityMetabolic Syndrome	1997	746
Systemic pan-AMPK activator MK-8722 improves glucose homeostasis but induces cardiac hypertrophy Robert W. Myers, Hong-Ping Guan, Juliann Ehrhart, Science Cardiac MuscleCardiovascular PharmacologyGlucose HomeostasisMetabolic RemodelingCardiovascular Function	2017	329
Comparison of the activity and disposition of the novel cholesterol absorption inhibitor, SCH58235, and its glucuronide, SCH60663 Margaret van Heek, Constance Farley, Douglas S. Compton, British Journal of Pharmacology	2000	327
In Vivo Metabolism-Based Discovery of a Potent Cholesterol Absorption Inhibitor, SCH58235, in the Rat and Rhesus Monkey through the Identification of the Active Metabolites of SCH48461 Margaret van Heek, Constance F. France, Douglas S. Compton, Journal of Pharmacology and Experimental Therapeutics	1997	305
Fat Intake Affects Adiposity, Comorbidity Factors, and Energy Metabolism of Sprague‐Dawley Rats Lorraine Ghibaudi, John A. Cook, Constance Farley, Obesity Research	2002	218
Ezetimibe selectively inhibits intestinal cholesterol absorption in rodents in the presence and absence of exocrine pancreatic function Margaret van Heek, Constance Farley, Douglas S. Compton, British Journal of Pharmacology Free CholesterolGastrointestinal PharmacologyGastroenterologyPlasma CholesterolDigestive Tract	2001	215
Leptin increases energy expenditure and selectively promotes fat metabolism in ob/ob mice Joyce Hwa, Ahmad Fawzi, Marco Graziano, American Journal of Physiology-Regulatory, Integrative and Comparative Physiology ObesityNutritionMetabolic SyndromeEnergy MetabolismFat Metabolism	1997	199
Ezetimibe improves high fat and cholesterol diet-induced non-alcoholic fatty liver disease in mice Shuqin Zheng, Lizbeth Hoos, John A. Cook, European Journal of Pharmacology ObesityMetabolic SyndromeNutritionHepatologyLipid Nutrition	2008	161
The cholesterol absorption inhibitor, ezetimibe, decreases diet-induced hypercholesterolemia in monkeys Margaret van Heek, Douglas S. Compton, Harry R. Davis European Journal of Pharmacology ObesityMetabolic SyndromeNutritionLipid DisorderMedicine	2001	130
Engineering Glucose Responsiveness Into Insulin Niels C. Kaarsholm, Songnian Lin, Lin Yan, Diabetes	2017	95

Page 1